Malaysian e-cigarette industry requests suspension of new regulations

Sep.24.2024
Malaysian e-cigarette industry requests suspension of new regulations
Malaysia's e-cigarette industry calls for a halt to new regulations under the Public Health Control Act 2024. (19 words)

According to Malaymail's report on September 23, local e-cigarette industry practitioners in Malaysia are calling on the government to temporarily suspend and reevaluate a series of new regulations under the Public Health (Control of Tobacco Products) Amendment Act 2024, stating that these regulations could potentially cripple the industry.


This legislation was announced on February 2nd of this year, with plans for it to take effect next month (October).


Datuk Adzwan Manas, chairman of the Malaysia Retail E-Cigarette Association (MRECA), stated that the Ministry of Health implemented new regulations at the last minute, following only one briefing session, leaving industry professionals with insufficient time to prepare for the transition.


Azwan mentioned that the new regulations include banning the display of e-cigarette products at store counters, reducing the maximum capacity of disposable e-cigarette liquid to 3 milliliters, and decreasing bottled e-cigarette liquid to 15 milliliters. However, the current market generally offers e-cigarette liquid capacities between 30 milliliters to 60 milliliters. He believes that the reduction should be gradual every two years rather than a significant decrease to 15 milliliters for disposables.


The Ministry of Health did not give all suppliers, manufacturers, and entrepreneurs enough time to complete their products. What are the manufacturers who are still producing products that may take another one or two months to complete, or those who have already ordered raw materials, supposed to do?


In addition, Azwan pointed out that the Ministry of Health has also requested for the gradual phase-out of existing stock within six months, but the industry needs at least a year to complete this process. The registration fee for each e-cigarette product is 5000 ringgit (approximately 1200 US dollars), which is significantly high as they have already paid a lot for Sirim certification and other regulatory requirements.


At a press conference following the submission of a memorandum to the Prime Minister's office, Azwan stated that a recent survey showed that most e-cigarette companies are willing to pay a registration fee of 500 to 900 Malaysian ringgit (120 to 215 USD) per product.


The memorandum was signed by five associations, namely MRECA, the Malaysian E-Cigarette and Tobacco Alternatives Association (MEVTA), the Malaysian E-Cigarette Industry Advocacy Group, the Malaysian E-Cigarette Traders Association and the Malaysian E-Cigarette Chamber of Commerce, collectively representing over 2000 e-cigarette traders.


Azwan stated that, given that the e-cigarette industry is also an important source of revenue for the country, these groups are still pushing for negotiations with the Ministry of Finance led by the Prime Minister. The e-cigarette industry also supports displaying products behind the counter, rather than the government's proposed total display ban, which would affect their business.


We have always supported regulation of the e-cigarette industry, but we hope it can be implemented gradually. Do not push us to the brink of collapse with stringent regulations at the last minute.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

PMI CEO Attends Opening of IQOS Global Flagship in Tokyo’s Ginza as 1,814 Limited ILUMA i PRIME Sets Launch
PMI CEO Attends Opening of IQOS Global Flagship in Tokyo’s Ginza as 1,814 Limited ILUMA i PRIME Sets Launch
IQOS opened its first global flagship, IQOS Flagship Ginza, in Tokyo on September 4, 2026, replacing the former IQOS Store Ginza after nearly a decade of operation. The new location expands conventional product retail into member lounges, digital experiences, art installations and brand programming. IQOS also launched a Ginza-exclusive IQOS ILUMA i PRIME set limited to 1,814 individually numbered units, priced at JPY11,980, or about US$77. PMI Sales Strategy Consultant Yuji M. later said on LinkedIn that more than 500 people had lined up from the night before the opening.
Sep.07
Product | SnowPlus Launches Nicotine-Free DASH in South Korea, Localising an Established Disposable Platform
Product | SnowPlus Launches Nicotine-Free DASH in South Korea, Localising an Established Disposable Platform
SnowPlus has introduced a nicotine-free version of DASH in South Korea, adapting an existing overseas disposable platform for the local market. The Korean version retains the series’ flat duckbill-style mouthpiece, ceramic heating architecture and disposable form factor while reducing nicotine content to 0%. By comparison, the overseas DASH 4000 platform typically features 7.5ml of prefilled e-liquid, up to 4,000 puffs and a 530mAh rechargeable battery, with nicotine-containing variants available in some markets. The product update centers on formulation localisation rather than a new hardware generation.
Aug.31
Swedish-Founded Nicotine Pouch Retailer GotPouches Shifts to U.S.-Based Operations, Reaching Over 25 States
Swedish-Founded Nicotine Pouch Retailer GotPouches Shifts to U.S.-Based Operations, Reaching Over 25 States
Swedish-founded online nicotine pouch retailer GotPouches has completed the localization of its U.S. operations under UpNorth Retail LLC, with corporate operations in Franklin, Tennessee, domestic fulfillment from Nashville and U.S.-based customer support. The company says its catalog covers more than 20 nicotine pouch brands and it currently serves customers in more than 25 U.S. states.
Sep.18
China Tobacco Yunnan files patent for cellulose-free nicotine pouch scaffold to replace microcrystalline cellulose
China Tobacco Yunnan files patent for cellulose-free nicotine pouch scaffold to replace microcrystalline cellulose
China Tobacco Yunnan Industrial Co., Ltd. has filed a patent application for a cellulose-free scaffold material for nicotine pouches, proposing a combination of bioceramic material, polydextrose and sugar alcohols to replace conventional microcrystalline cellulose and cellulose derivatives. The filing aims to address issues including powdery mouthfeel, residue and limited release control, while also reducing reliance on existing cellulose-based patent portfolios. In patent examples, one fast-release formulation reached a nicotine release rate of 50% at 10 minutes and more than 90% at 20 minutes.
Sep.02
U.S. Health Groups Seek to Overturn FDA Enforcement Discretion for Pending PMTAs as Altria's Helix, NJOY and AVM Move to Intervene
U.S. Health Groups Seek to Overturn FDA Enforcement Discretion for Pending PMTAs as Altria's Helix, NJOY and AVM Move to Intervene
American Vapor Manufacturers (AVM) and Altria subsidiaries Helix Innovations and NJOY filed separate motions on October 7, 2026, seeking to intervene on the FDA's side in a lawsuit challenging its enforcement guidance for certain e-cigarette and nicotine pouch products with pending premarket tobacco product applications (PMTAs). Seven public health and tobacco-control organizations, including the Campaign for Tobacco-Free Kids, sued the agency in July to overturn the policy. AVM argues that vacating the guidance could disrupt orders, inventory, retail distribution and investments in regulatory submissions.
Regulations
Oct.09
Cochrane 2026 Update Adds Nine Trials, Keeps High-Certainty Finding That Nicotine E-Cigarettes Improve Quit Rates Over NRT
Cochrane 2026 Update Adds Nine Trials, Keeps High-Certainty Finding That Nicotine E-Cigarettes Improve Quit Rates Over NRT
Cochrane’s 2026 update of its living review on electronic cigarettes for smoking cessation included 80 randomized controlled trials involving 29,861 adult smokers, with nine trials added in this update. The review retained its high-certainty conclusion that nicotine e-cigarettes increase smoking cessation rates compared with nicotine replacement therapy. In absolute terms, about 10 in 100 people using nicotine e-cigarettes may quit smoking for at least six months, compared with about 6 in 100 using NRT. The review found no clear difference in serious adverse event rates between the two groups, while longer-term safety and the relative effectiveness of newer device types remain less certain.
Sep.07